1-3 of 3
Naoki Kaneko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression

Hiroaki Tanaka, Hideki Sakagami, Naoki Kaneko, Satoshi Konagai, Hiroko Yamamoto, Takahiro Matsuya, Masatoshi Yuri, Yosuke Yamanaka, Masamichi Mori, Masahiro Takeuchi, Hiroyuki Koshio, Masaaki Hirano, Sadao Kuromitsu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (8): 1366–1373.
https://doi.org/10.1158/1535-7163.MCT-18-0976
Published: 01 August 2019
View article titled, Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression
Open the PDF for Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression in another window
Includes: Supplementary data
Journal Articles

Abstract B188: Preclinical antitumor activity of ASP8273, a mutant-selective irreversible EGFR inhibitor in an AXL-overexpressing NSCLC model

Naoki Kaneko, Hiroaki Tanaka, Satoshi Konagai, Hiroko Yamamoto, Hideki Sakagami, Tomohiro Eguchi, Takahiro Matsuya, Masamichi Mori, Hiroyuki Koshio, Tadashi Terasaka, Masaaki Hirano, Sadao Kuromitsu, Masahiro Takeuchi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B188.
https://doi.org/10.1158/1535-7163.TARG-15-B188
Published: 01 December 2015
View article titled, Abstract B188: Preclinical antitumor activity of ASP8273, a mutant-selective irreversible EGFR inhibitor in an AXL-overexpressing NSCLC model
Journal Articles

Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents

Hiroshi Hirai, Yoshikazu Iwasawa, Megumu Okada, Tsuyoshi Arai, Toshihide Nishibata, Makiko Kobayashi, Toshifumi Kimura, Naoki Kaneko, Junko Ohtani, Kazunori Yamanaka, Hiraku Itadani, Ikuko Takahashi-Suzuki, Kazuhiro Fukasawa, Hiroko Oki, Tadahiro Nambu, Jian Jiang, Takumi Sakai, Hiroharu Arakawa, Toshihiro Sakamoto, Takeshi Sagara, Takashi Yoshizumi, Shinji Mizuarai, Hidehito Kotani
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 2992–3000.
https://doi.org/10.1158/1535-7163.MCT-09-0463
Published: 10 November 2009
View article titled, Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
Open the PDF for Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents in another window
Includes: Supplementary data